These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 4537955)

  • 21. [Treatment of arterial hypertension with alpha-methyldopa].
    Herteanu H; Bucur V
    Med Interna (Bucur); 1969 Sep; 21(9):1119-26. PubMed ID: 5378243
    [No Abstract]   [Full Text] [Related]  

  • 22. Excretion patterns of tryptamine, indoleacetic acid, and 5-hydroxyindoleacetic acid, and their correlation with mental changes in schizophrenic patients under medication with alpha-methyldopa.
    Herkert EE; Keup W
    Psychopharmacologia; 1969; 15(1):48-59. PubMed ID: 5367444
    [No Abstract]   [Full Text] [Related]  

  • 23. Uptake and utilization of ( 3 H-)5-hydroxytryptophan by brain tissue during development.
    Kellogg C; Lundborg P
    Neuropharmacology; 1972 May; 11(3):363-72. PubMed ID: 4538097
    [No Abstract]   [Full Text] [Related]  

  • 24. [Therapy of essential arterial hypertension. V].
    Fossati C
    Clin Ter; 1980 Jun; 93(5):577-94. PubMed ID: 6107196
    [No Abstract]   [Full Text] [Related]  

  • 25. [Arterial hypertenson. II. Effect of treatment on survival, with special reference to renal function].
    Moyer JH; O'Malley J; Brest AN
    Stud Cercet Med Interna; 1966; 7(6):579-87. PubMed ID: 5962827
    [No Abstract]   [Full Text] [Related]  

  • 26. Decarboxylation of exogenous L-5-hydroxytryptophan after destruction of the cerebral raphe system.
    Korf J; Venema K; Postema F
    J Neurochem; 1974 Jul; 23(1):249-52. PubMed ID: 4136623
    [No Abstract]   [Full Text] [Related]  

  • 27. [Objectives and methods in therapy of essential arterial hypertension].
    Zanchetti A
    Cardiol Prat; 1968 Aug; 19(4):263-6. PubMed ID: 5746811
    [No Abstract]   [Full Text] [Related]  

  • 28. [The importance of determining 5-hydroxytryptophan and hydroxyindoles in biological fluids in cancer cases].
    Bousquet B; Dreux C; Girard ML
    C R Acad Hebd Seances Acad Sci D; 1975 Feb; 280(8):1043-6. PubMed ID: 809189
    [No Abstract]   [Full Text] [Related]  

  • 29. [Antihypertensive action of 4 drugs inhibiting the sympathetic nervous system. Preliminary hemodynamic study].
    Weiss Y; Merceron R; Safar M; Milliez P
    Coeur Med Interne; 1973; 12(3):425-9. PubMed ID: 4733293
    [No Abstract]   [Full Text] [Related]  

  • 30. [Medical therapy of arterial hypertension].
    Dalla Volta S
    Cardiol Prat; 1968 Oct; 19(5):357-67. PubMed ID: 5733216
    [No Abstract]   [Full Text] [Related]  

  • 31. Beta receptor antagonism in hypertension; comparison with the effect of adrenergic neurone inhibition on cardiovascular responses.
    Prichard BN; Gillam PM; Graham BR
    Int Z Klin Pharmakol Ther Toxikol; 1970 Dec; 4(1):131-40. PubMed ID: 4924319
    [No Abstract]   [Full Text] [Related]  

  • 32. Contribution of the central nervous system to the action of several antihypertensive agents (methyldopa, hydralazine and guanethidine).
    Baum T; Shropshire AT; Varner LL
    J Pharmacol Exp Ther; 1972 Jul; 182(1):135-44. PubMed ID: 5041650
    [No Abstract]   [Full Text] [Related]  

  • 33. Drug interactions with guanethidine.
    Ober KF; Wang RI
    Clin Pharmacol Ther; 1973; 14(2):190-5. PubMed ID: 4695380
    [No Abstract]   [Full Text] [Related]  

  • 34. [Urinary excretion of vanilmandelic acid in rats with experimental hypertension, treated with alpha methyldopa].
    Pirrelli A; Pieri R; Dolce E; Savino L; Misceo N
    Boll Soc Ital Biol Sper; 1978 Dec; 54(24):2545-9. PubMed ID: 756276
    [No Abstract]   [Full Text] [Related]  

  • 35. [Excretion of alpha-methylnoradrenaline in the urine of hypertensive patients during treatment with alpha-methyldopa].
    Muscholl E; Rahn KH
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 257(1):44-5. PubMed ID: 4231857
    [No Abstract]   [Full Text] [Related]  

  • 36. 'Sweet Dreams', 'Happy Days' and elevated 24-h urine 5-hydroxyindoleacetic acid excretion.
    Hallin ML; Mahmoud K; Viswanath A; Gama R
    Ann Clin Biochem; 2013 Jan; 50(Pt 1):80-2. PubMed ID: 23086978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Drugs in the management of arterial hypertension].
    Rev Clin Esp; 1969 Jan; 112(2):207. PubMed ID: 5769042
    [No Abstract]   [Full Text] [Related]  

  • 38. [May medical therapy of arterial hypertension by used in patients with renal failure?].
    Richet G; Ducrot H; Hamburger J; Legrain M; Maxwell M; Péquignot MH
    Presse Med (1893); 1968 Nov; 76(44):2103-6. PubMed ID: 5701039
    [No Abstract]   [Full Text] [Related]  

  • 39. Progress report: the carcinoid syndrome.
    Grahame-Smith DG
    Gut; 1970 Feb; 11(2):189-92. PubMed ID: 4913426
    [No Abstract]   [Full Text] [Related]  

  • 40. Antihypertensive action of benzothiadiazines.
    Freis ED
    N Y State J Med; 1968 Jan; 68(2):259-64. PubMed ID: 4865596
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.